» Articles » PMID: 24402395

Characteristics of Polymedicated (≥ 4) Elderly: a Survey in a Community-dwelling Population Aged 60 Years and over

Overview
Date 2014 Jan 10
PMID 24402395
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polypharmacy is an important concern for patient safety and has been associated with increased adverse drug reactions, hospitalization and mortality in the elderly.

Objective: In light of the above, the present study aimed to assess the major characteristics associated with polypharmacy (≥ 4 drugs) in a larger population of apparently healthy older subjects over 60 years.

Study-design: Cross-sectional study.

Setting: The preventive medical center (CMP) in Nancy.

Participants: 2,545 volunteers (1,175 women, 1,370 men) aged 60 years and older (66 ± 4.8 years) were included from the Senior health examination study.

Measurements: All subjects underwent clinical, biological examinations. Sociodemographic data, practice of regular physical activity and drug intake data were collected. A self-administered questionnaire of health status, psychological status and questions regarding falls were collected.

Results: The prevalence of polypharmacy in this study was 29.9%. The number of drugs in polymedicated people was 5.67 ± 1.82 versus 1.32 ± 1.11 in non polymedicated people; p≤0.01. Multivariate analyses identified 6 independent variables associated with polypharmacy: age over 65 years (OR = 1.58 95% CI: [1.05 - 2.38]; p = 0.03), poor self-perceived health status (2.79 [1.80 - 4.31]; p ≤ 0,01), history of falls (1.66 [1.02 - 2.71]; p = 0.04), lack of a physical activity (1.50 [1.001 - 2.26]; p = 0.049), metabolic syndrome (3.17 [1.95 - 5.15]; p ≤ 0,01), low or medium education level (2.20 [1.24 - 4.30]; p = 0.02).

Conclusion: Among community-dwelling people aged 60 years and over, in addition to the presence of several diseases and advanced age, the psychological and socio-educative factors may influence drug intake and polypharmacy in the elderly. Physicians should be take into account these considerations before issuing any prescriptions and review all medications used at every visit to avoid unnecessary addictions or dangerous drug-drug interactions.

Citing Articles

Telemonitoring in Chronic Heart Failure Among the Elderly: A Rapid Review of Literature.

Roaquin L, Apsay K, Pangan C, Hangdaan L, Lin Y SAGE Open Nurs. 2025; 11:23779608251316823.

PMID: 39958190 PMC: 11826847. DOI: 10.1177/23779608251316823.


Uses and perceptions of medications among French older adults: results from the 2020 French Health Barometer survey.

Tran A, Soullier N, Ankri J, Herr M, Carcaillon-Bentata L BMC Geriatr. 2022; 22(1):602.

PMID: 35858861 PMC: 9301842. DOI: 10.1186/s12877-022-03289-9.


The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.

Lee G, Etherton-Beer C, Hosking S, Pasco J, Page A Ther Adv Drug Saf. 2022; 13:20420986221100117.

PMID: 35814333 PMC: 9260603. DOI: 10.1177/20420986221100117.


Better Medicines for Older Patients: Considerations between Patient Characteristics and Solid Oral Dosage Form Designs to Improve Swallowing Experience.

Drumond N, Stegemann S Pharmaceutics. 2020; 13(1).

PMID: 33379258 PMC: 7824227. DOI: 10.3390/pharmaceutics13010032.


Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort.

van Oort S, Rutters F, Warle-van Herwaarden M, Schram M, Stehouwer C, Tack C Diabet Med. 2020; 38(4):e14406.

PMID: 32961611 PMC: 8048843. DOI: 10.1111/dme.14406.


References
1.
Montamat S, Cusack B . Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med. 1992; 8(1):143-58. View

2.
Hajjar E, Cafiero A, Hanlon J . Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2008; 5(4):345-51. DOI: 10.1016/j.amjopharm.2007.12.002. View

3.
Ziere G, Dieleman J, Hofman A, Pols H, van der Cammen T, Stricker B . Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006; 61(2):218-23. PMC: 1885000. DOI: 10.1111/j.1365-2125.2005.02543.x. View

4.
Nielsen M, Hansen E, Rasmussen N . Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol. 2003; 59(8-9):677-84. DOI: 10.1007/s00228-003-0678-z. View

5.
Lahelma E, Kivela K, Roos E, Tuominen T, Dahl E, Diderichsen F . Analysing changes of health inequalities in the Nordic welfare states. Soc Sci Med. 2002; 55(4):609-25. DOI: 10.1016/s0277-9536(01)00191-5. View